ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Viral Vector and Plasmid DNA Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-23M8886
Home | Market Reports | Science| Biological Sciences
Global Viral Vector and Plasmid DNA Market Size Status and Forecast 2022
BUY CHAPTERS

Global Viral Vector and Plasmid DNA Market Research Report 2024

Code: QYRE-Auto-23M8886
Report
February 2024
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Brammer Bio
Oxford BioMedica
Cobra Biologics
FinVector
Lonza
BioReliance
Molmed
FUJIFILM Diosynth Biotechnologies
Uniqure
Aldevron
Richter-Helm
Eurogentec S.A
OBiO Technology
Yposkesi
Cell and Gene Therapy Catapult
MassBiologics
Biovian
VGXI
Gene Synthesis
PlasmidFactory
Jikai Gene

Viral Vector and Plasmid DNA Market Size

The global Viral Vector and Plasmid DNA market was valued at US$ 667.5 million in 2023 and is anticipated to reach US$ 2327.4 million by 2030, witnessing a CAGR of 19.3% during the forecast period 2024-2030.

Viral Vector and Plasmid DNA Market

Viral Vector and Plasmid DNA Market

Viral vectors carry genetic material into cells by exploiting the molecular mechanisms by which viruses transmit their genomes to other cells for infection.It can occur in vivo or in vitro.Plasmid carriers are plasmids artificially constructed on the basis of natural plasmids to adapt to laboratory operations.In recent years, global viral vector and plasmid DNA manufacturing has developed rapidly, with a compound growth rate of about 28% during 2018-2018.In 2018, global sales of viral vector and plasmid DNA production reached $381 million.In 2018, China accounted for about 4% of global sales.In the next five years, the production of viral vectors and plasmid DNA products in China will continue to grow rapidly.Viral vector and plasmid DNA manufacturing are mainly divided into viral vector manufacturing and plasmid DNA manufacturing, among which viral vector manufacturing accounts for the largest proportion, accounting for nearly 38% of the total market in 2018.Viral vector and plasmid DNA manufacturing is mainly used for drug development and production of cancer, genetic diseases, viral infections and other diseases, among which cancer is the main application field, accounting for 35% in 2018.The market is highly competitive.Brammer Bio, Oxford BioMedica, Cobra Biologics, FinVector and Lonza are major suppliers.They have mastered key technologies and patents, and they have a fixed customer base. They have established a monopoly in the market.Gene therapy technology innovation and clinical trials have mushroomed in recent years, and a number of gene therapy projects have been approved for marketing in the United States, the European Union, China and other countries.The target of gene therapy has also been gradually expanded from single gene genetic diseases to malignant tumors, infectious diseases, cardiovascular diseases, autoimmune diseases, metabolic diseases and other major diseases.
Global Viral Vector and Plasmid DNA key players include BioReliance, Oxford BioMedica, UniQure, Cobra Biologics, etc. Global top four manufacturers hold a share over 45%.
North America is the largest market, with a share about 50%, followed by Europe, and Asia-Pacific, both have a share over 40 percent.
In terms of product, Viral Vectors is the largest segment, with a share about 80%. And in terms of application, the largest application is Cancers, followed by Inherited Disorders, Viral Infections, etc.
This report aims to provide a comprehensive presentation of the global market for Viral Vector and Plasmid DNA, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector and Plasmid DNA.

Report Scope

The Viral Vector and Plasmid DNA market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral Vector and Plasmid DNA market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Vector and Plasmid DNA companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Viral Vector and Plasmid DNA Market Report

Report Metric Details
Report Name Viral Vector and Plasmid DNA Market
Accounted market size in 2023 US$ 667.5 million
Forecasted market size in 2030 US$ 2327.4 million
CAGR 19.3%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Plasmid DNA
  • Viral Vector
Segment by Application
  • Cancer
  • Virus Infection
  • Hereditary Disease
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Brammer Bio, Oxford BioMedica, Cobra Biologics, FinVector, Lonza, BioReliance, MolMed, FUJIFILM Diosynth Biotechnologies, UniQure, Aldevron, Richter-Helm, Eurogentec, OBiO Technology, Yposkesi, Cell and Gene Therapy Catapult, MassBiologics, Biovian, VGXI, Gene Synthesis, PlasmidFactory, Jikai Gene
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Viral Vector and Plasmid DNA companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Viral Vector and Plasmid DNA Market growing?

Ans: The Viral Vector and Plasmid DNA Market witnessing a CAGR of 19.3% during the forecast period 2024-2030.

What is the Viral Vector and Plasmid DNA Market size in 2030?

Ans: The Viral Vector and Plasmid DNA Market size in 2030 will be US$ 2327.4 million.

What is the Viral Vector and Plasmid DNA Market share by region?

Ans: In 2018, China accounted for about 4% of global sales.

What is the market share of major companies in Viral Vector and Plasmid DNA Market?

Ans: Global top four manufacturers hold a share over 45%.

Who are the main players in the Viral Vector and Plasmid DNA Market report?

Ans: The main players in the Viral Vector and Plasmid DNA Market are Brammer Bio, Oxford BioMedica, Cobra Biologics, FinVector, Lonza, BioReliance, MolMed, FUJIFILM Diosynth Biotechnologies, UniQure, Aldevron, Richter-Helm, Eurogentec, OBiO Technology, Yposkesi, Cell and Gene Therapy Catapult, MassBiologics, Biovian, VGXI, Gene Synthesis, PlasmidFactory, Jikai Gene

What are the Application segmentation covered in the Viral Vector and Plasmid DNA Market report?

Ans: The Applications covered in the Viral Vector and Plasmid DNA Market report are Cancer, Virus Infection, Hereditary Disease

What are the Type segmentation covered in the Viral Vector and Plasmid DNA Market report?

Ans: The Types covered in the Viral Vector and Plasmid DNA Market report are Plasmid DNA, Viral Vector

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector and Plasmid DNA Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Plasmid DNA
1.2.3 Viral Vector
1.3 Market by Application
1.3.1 Global Viral Vector and Plasmid DNA Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Virus Infection
1.3.4 Hereditary Disease
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vector and Plasmid DNA Market Perspective (2019-2030)
2.2 Viral Vector and Plasmid DNA Growth Trends by Region
2.2.1 Global Viral Vector and Plasmid DNA Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Viral Vector and Plasmid DNA Historic Market Size by Region (2019-2024)
2.2.3 Viral Vector and Plasmid DNA Forecasted Market Size by Region (2025-2030)
2.3 Viral Vector and Plasmid DNA Market Dynamics
2.3.1 Viral Vector and Plasmid DNA Industry Trends
2.3.2 Viral Vector and Plasmid DNA Market Drivers
2.3.3 Viral Vector and Plasmid DNA Market Challenges
2.3.4 Viral Vector and Plasmid DNA Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vector and Plasmid DNA Players by Revenue
3.1.1 Global Top Viral Vector and Plasmid DNA Players by Revenue (2019-2024)
3.1.2 Global Viral Vector and Plasmid DNA Revenue Market Share by Players (2019-2024)
3.2 Global Viral Vector and Plasmid DNA Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Vector and Plasmid DNA Revenue
3.4 Global Viral Vector and Plasmid DNA Market Concentration Ratio
3.4.1 Global Viral Vector and Plasmid DNA Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector and Plasmid DNA Revenue in 2023
3.5 Viral Vector and Plasmid DNA Key Players Head office and Area Served
3.6 Key Players Viral Vector and Plasmid DNA Product Solution and Service
3.7 Date of Enter into Viral Vector and Plasmid DNA Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector and Plasmid DNA Breakdown Data by Type
4.1 Global Viral Vector and Plasmid DNA Historic Market Size by Type (2019-2024)
4.2 Global Viral Vector and Plasmid DNA Forecasted Market Size by Type (2025-2030)
5 Viral Vector and Plasmid DNA Breakdown Data by Application
5.1 Global Viral Vector and Plasmid DNA Historic Market Size by Application (2019-2024)
5.2 Global Viral Vector and Plasmid DNA Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Viral Vector and Plasmid DNA Market Size (2019-2030)
6.2 North America Viral Vector and Plasmid DNA Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Viral Vector and Plasmid DNA Market Size by Country (2019-2024)
6.4 North America Viral Vector and Plasmid DNA Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vector and Plasmid DNA Market Size (2019-2030)
7.2 Europe Viral Vector and Plasmid DNA Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Viral Vector and Plasmid DNA Market Size by Country (2019-2024)
7.4 Europe Viral Vector and Plasmid DNA Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vector and Plasmid DNA Market Size (2019-2030)
8.2 Asia-Pacific Viral Vector and Plasmid DNA Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Region (2019-2024)
8.4 Asia-Pacific Viral Vector and Plasmid DNA Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Vector and Plasmid DNA Market Size (2019-2030)
9.2 Latin America Viral Vector and Plasmid DNA Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Viral Vector and Plasmid DNA Market Size by Country (2019-2024)
9.4 Latin America Viral Vector and Plasmid DNA Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vector and Plasmid DNA Market Size (2019-2030)
10.2 Middle East & Africa Viral Vector and Plasmid DNA Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Country (2019-2024)
10.4 Middle East & Africa Viral Vector and Plasmid DNA Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Brammer Bio
11.1.1 Brammer Bio Company Detail
11.1.2 Brammer Bio Business Overview
11.1.3 Brammer Bio Viral Vector and Plasmid DNA Introduction
11.1.4 Brammer Bio Revenue in Viral Vector and Plasmid DNA Business (2019-2024)
11.1.5 Brammer Bio Recent Development
11.2 Oxford BioMedica
11.2.1 Oxford BioMedica Company Detail
11.2.2 Oxford BioMedica Business Overview
11.2.3 Oxford BioMedica Viral Vector and Plasmid DNA Introduction
11.2.4 Oxford BioMedica Revenue in Viral Vector and Plasmid DNA Business (2019-2024)
11.2.5 Oxford BioMedica Recent Development
11.3 Cobra Biologics
11.3.1 Cobra Biologics Company Detail
11.3.2 Cobra Biologics Business Overview
11.3.3 Cobra Biologics Viral Vector and Plasmid DNA Introduction
11.3.4 Cobra Biologics Revenue in Viral Vector and Plasmid DNA Business (2019-2024)
11.3.5 Cobra Biologics Recent Development
11.4 FinVector
11.4.1 FinVector Company Detail
11.4.2 FinVector Business Overview
11.4.3 FinVector Viral Vector and Plasmid DNA Introduction
11.4.4 FinVector Revenue in Viral Vector and Plasmid DNA Business (2019-2024)
11.4.5 FinVector Recent Development
11.5 Lonza
11.5.1 Lonza Company Detail
11.5.2 Lonza Business Overview
11.5.3 Lonza Viral Vector and Plasmid DNA Introduction
11.5.4 Lonza Revenue in Viral Vector and Plasmid DNA Business (2019-2024)
11.5.5 Lonza Recent Development
11.6 BioReliance
11.6.1 BioReliance Company Detail
11.6.2 BioReliance Business Overview
11.6.3 BioReliance Viral Vector and Plasmid DNA Introduction
11.6.4 BioReliance Revenue in Viral Vector and Plasmid DNA Business (2019-2024)
11.6.5 BioReliance Recent Development
11.7 MolMed
11.7.1 MolMed Company Detail
11.7.2 MolMed Business Overview
11.7.3 MolMed Viral Vector and Plasmid DNA Introduction
11.7.4 MolMed Revenue in Viral Vector and Plasmid DNA Business (2019-2024)
11.7.5 MolMed Recent Development
11.8 FUJIFILM Diosynth Biotechnologies
11.8.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.8.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.8.3 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Introduction
11.8.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector and Plasmid DNA Business (2019-2024)
11.8.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.9 UniQure
11.9.1 UniQure Company Detail
11.9.2 UniQure Business Overview
11.9.3 UniQure Viral Vector and Plasmid DNA Introduction
11.9.4 UniQure Revenue in Viral Vector and Plasmid DNA Business (2019-2024)
11.9.5 UniQure Recent Development
11.10 Aldevron
11.10.1 Aldevron Company Detail
11.10.2 Aldevron Business Overview
11.10.3 Aldevron Viral Vector and Plasmid DNA Introduction
11.10.4 Aldevron Revenue in Viral Vector and Plasmid DNA Business (2019-2024)
11.10.5 Aldevron Recent Development
11.11 Richter-Helm
11.11.1 Richter-Helm Company Detail
11.11.2 Richter-Helm Business Overview
11.11.3 Richter-Helm Viral Vector and Plasmid DNA Introduction
11.11.4 Richter-Helm Revenue in Viral Vector and Plasmid DNA Business (2019-2024)
11.11.5 Richter-Helm Recent Development
11.12 Eurogentec
11.12.1 Eurogentec Company Detail
11.12.2 Eurogentec Business Overview
11.12.3 Eurogentec Viral Vector and Plasmid DNA Introduction
11.12.4 Eurogentec Revenue in Viral Vector and Plasmid DNA Business (2019-2024)
11.12.5 Eurogentec Recent Development
11.13 OBiO Technology
11.13.1 OBiO Technology Company Detail
11.13.2 OBiO Technology Business Overview
11.13.3 OBiO Technology Viral Vector and Plasmid DNA Introduction
11.13.4 OBiO Technology Revenue in Viral Vector and Plasmid DNA Business (2019-2024)
11.13.5 OBiO Technology Recent Development
11.14 Yposkesi
11.14.1 Yposkesi Company Detail
11.14.2 Yposkesi Business Overview
11.14.3 Yposkesi Viral Vector and Plasmid DNA Introduction
11.14.4 Yposkesi Revenue in Viral Vector and Plasmid DNA Business (2019-2024)
11.14.5 Yposkesi Recent Development
11.15 Cell and Gene Therapy Catapult
11.15.1 Cell and Gene Therapy Catapult Company Detail
11.15.2 Cell and Gene Therapy Catapult Business Overview
11.15.3 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Introduction
11.15.4 Cell and Gene Therapy Catapult Revenue in Viral Vector and Plasmid DNA Business (2019-2024)
11.15.5 Cell and Gene Therapy Catapult Recent Development
11.16 MassBiologics
11.16.1 MassBiologics Company Detail
11.16.2 MassBiologics Business Overview
11.16.3 MassBiologics Viral Vector and Plasmid DNA Introduction
11.16.4 MassBiologics Revenue in Viral Vector and Plasmid DNA Business (2019-2024)
11.16.5 MassBiologics Recent Development
11.17 Biovian
11.17.1 Biovian Company Detail
11.17.2 Biovian Business Overview
11.17.3 Biovian Viral Vector and Plasmid DNA Introduction
11.17.4 Biovian Revenue in Viral Vector and Plasmid DNA Business (2019-2024)
11.17.5 Biovian Recent Development
11.18 VGXI
11.18.1 VGXI Company Detail
11.18.2 VGXI Business Overview
11.18.3 VGXI Viral Vector and Plasmid DNA Introduction
11.18.4 VGXI Revenue in Viral Vector and Plasmid DNA Business (2019-2024)
11.18.5 VGXI Recent Development
11.19 Gene Synthesis
11.19.1 Gene Synthesis Company Detail
11.19.2 Gene Synthesis Business Overview
11.19.3 Gene Synthesis Viral Vector and Plasmid DNA Introduction
11.19.4 Gene Synthesis Revenue in Viral Vector and Plasmid DNA Business (2019-2024)
11.19.5 Gene Synthesis Recent Development
11.20 PlasmidFactory
11.20.1 PlasmidFactory Company Detail
11.20.2 PlasmidFactory Business Overview
11.20.3 PlasmidFactory Viral Vector and Plasmid DNA Introduction
11.20.4 PlasmidFactory Revenue in Viral Vector and Plasmid DNA Business (2019-2024)
11.20.5 PlasmidFactory Recent Development
11.21 Jikai Gene
11.21.1 Jikai Gene Company Detail
11.21.2 Jikai Gene Business Overview
11.21.3 Jikai Gene Viral Vector and Plasmid DNA Introduction
11.21.4 Jikai Gene Revenue in Viral Vector and Plasmid DNA Business (2019-2024)
11.21.5 Jikai Gene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Brammer Bio
Oxford BioMedica
Cobra Biologics
FinVector
Lonza
BioReliance
Molmed
FUJIFILM Diosynth Biotechnologies
Uniqure
Aldevron
Richter-Helm
Eurogentec S.A
OBiO Technology
Yposkesi
Cell and Gene Therapy Catapult
MassBiologics
Biovian
VGXI
Gene Synthesis
PlasmidFactory
Jikai Gene
List of Tables
    Table 1. Global Viral Vector and Plasmid DNA Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Plasmid DNA
    Table 3. Key Players of Viral Vector
    Table 4. Global Viral Vector and Plasmid DNA Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Viral Vector and Plasmid DNA Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Viral Vector and Plasmid DNA Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Viral Vector and Plasmid DNA Market Share by Region (2019-2024)
    Table 8. Global Viral Vector and Plasmid DNA Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Viral Vector and Plasmid DNA Market Share by Region (2025-2030)
    Table 10. Viral Vector and Plasmid DNA Market Trends
    Table 11. Viral Vector and Plasmid DNA Market Drivers
    Table 12. Viral Vector and Plasmid DNA Market Challenges
    Table 13. Viral Vector and Plasmid DNA Market Restraints
    Table 14. Global Viral Vector and Plasmid DNA Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Viral Vector and Plasmid DNA Market Share by Players (2019-2024)
    Table 16. Global Top Viral Vector and Plasmid DNA Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector and Plasmid DNA as of 2023)
    Table 17. Ranking of Global Top Viral Vector and Plasmid DNA Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Viral Vector and Plasmid DNA Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Viral Vector and Plasmid DNA Product Solution and Service
    Table 21. Date of Enter into Viral Vector and Plasmid DNA Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Viral Vector and Plasmid DNA Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Viral Vector and Plasmid DNA Revenue Market Share by Type (2019-2024)
    Table 25. Global Viral Vector and Plasmid DNA Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Viral Vector and Plasmid DNA Revenue Market Share by Type (2025-2030)
    Table 27. Global Viral Vector and Plasmid DNA Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Viral Vector and Plasmid DNA Revenue Market Share by Application (2019-2024)
    Table 29. Global Viral Vector and Plasmid DNA Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Viral Vector and Plasmid DNA Revenue Market Share by Application (2025-2030)
    Table 31. North America Viral Vector and Plasmid DNA Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Viral Vector and Plasmid DNA Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Viral Vector and Plasmid DNA Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Viral Vector and Plasmid DNA Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Viral Vector and Plasmid DNA Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Viral Vector and Plasmid DNA Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Viral Vector and Plasmid DNA Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Viral Vector and Plasmid DNA Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Viral Vector and Plasmid DNA Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Viral Vector and Plasmid DNA Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Viral Vector and Plasmid DNA Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Viral Vector and Plasmid DNA Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Viral Vector and Plasmid DNA Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Viral Vector and Plasmid DNA Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Viral Vector and Plasmid DNA Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Brammer Bio Company Detail
    Table 47. Brammer Bio Business Overview
    Table 48. Brammer Bio Viral Vector and Plasmid DNA Product
    Table 49. Brammer Bio Revenue in Viral Vector and Plasmid DNA Business (2019-2024) & (US$ Million)
    Table 50. Brammer Bio Recent Development
    Table 51. Oxford BioMedica Company Detail
    Table 52. Oxford BioMedica Business Overview
    Table 53. Oxford BioMedica Viral Vector and Plasmid DNA Product
    Table 54. Oxford BioMedica Revenue in Viral Vector and Plasmid DNA Business (2019-2024) & (US$ Million)
    Table 55. Oxford BioMedica Recent Development
    Table 56. Cobra Biologics Company Detail
    Table 57. Cobra Biologics Business Overview
    Table 58. Cobra Biologics Viral Vector and Plasmid DNA Product
    Table 59. Cobra Biologics Revenue in Viral Vector and Plasmid DNA Business (2019-2024) & (US$ Million)
    Table 60. Cobra Biologics Recent Development
    Table 61. FinVector Company Detail
    Table 62. FinVector Business Overview
    Table 63. FinVector Viral Vector and Plasmid DNA Product
    Table 64. FinVector Revenue in Viral Vector and Plasmid DNA Business (2019-2024) & (US$ Million)
    Table 65. FinVector Recent Development
    Table 66. Lonza Company Detail
    Table 67. Lonza Business Overview
    Table 68. Lonza Viral Vector and Plasmid DNA Product
    Table 69. Lonza Revenue in Viral Vector and Plasmid DNA Business (2019-2024) & (US$ Million)
    Table 70. Lonza Recent Development
    Table 71. BioReliance Company Detail
    Table 72. BioReliance Business Overview
    Table 73. BioReliance Viral Vector and Plasmid DNA Product
    Table 74. BioReliance Revenue in Viral Vector and Plasmid DNA Business (2019-2024) & (US$ Million)
    Table 75. BioReliance Recent Development
    Table 76. MolMed Company Detail
    Table 77. MolMed Business Overview
    Table 78. MolMed Viral Vector and Plasmid DNA Product
    Table 79. MolMed Revenue in Viral Vector and Plasmid DNA Business (2019-2024) & (US$ Million)
    Table 80. MolMed Recent Development
    Table 81. FUJIFILM Diosynth Biotechnologies Company Detail
    Table 82. FUJIFILM Diosynth Biotechnologies Business Overview
    Table 83. FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Product
    Table 84. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector and Plasmid DNA Business (2019-2024) & (US$ Million)
    Table 85. FUJIFILM Diosynth Biotechnologies Recent Development
    Table 86. UniQure Company Detail
    Table 87. UniQure Business Overview
    Table 88. UniQure Viral Vector and Plasmid DNA Product
    Table 89. UniQure Revenue in Viral Vector and Plasmid DNA Business (2019-2024) & (US$ Million)
    Table 90. UniQure Recent Development
    Table 91. Aldevron Company Detail
    Table 92. Aldevron Business Overview
    Table 93. Aldevron Viral Vector and Plasmid DNA Product
    Table 94. Aldevron Revenue in Viral Vector and Plasmid DNA Business (2019-2024) & (US$ Million)
    Table 95. Aldevron Recent Development
    Table 96. Richter-Helm Company Detail
    Table 97. Richter-Helm Business Overview
    Table 98. Richter-Helm Viral Vector and Plasmid DNA Product
    Table 99. Richter-Helm Revenue in Viral Vector and Plasmid DNA Business (2019-2024) & (US$ Million)
    Table 100. Richter-Helm Recent Development
    Table 101. Eurogentec Company Detail
    Table 102. Eurogentec Business Overview
    Table 103. Eurogentec Viral Vector and Plasmid DNA Product
    Table 104. Eurogentec Revenue in Viral Vector and Plasmid DNA Business (2019-2024) & (US$ Million)
    Table 105. Eurogentec Recent Development
    Table 106. OBiO Technology Company Detail
    Table 107. OBiO Technology Business Overview
    Table 108. OBiO Technology Viral Vector and Plasmid DNA Product
    Table 109. OBiO Technology Revenue in Viral Vector and Plasmid DNA Business (2019-2024) & (US$ Million)
    Table 110. OBiO Technology Recent Development
    Table 111. Yposkesi Company Detail
    Table 112. Yposkesi Business Overview
    Table 113. Yposkesi Viral Vector and Plasmid DNA Product
    Table 114. Yposkesi Revenue in Viral Vector and Plasmid DNA Business (2019-2024) & (US$ Million)
    Table 115. Yposkesi Recent Development
    Table 116. Cell and Gene Therapy Catapult Company Detail
    Table 117. Cell and Gene Therapy Catapult Business Overview
    Table 118. Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Product
    Table 119. Cell and Gene Therapy Catapult Revenue in Viral Vector and Plasmid DNA Business (2019-2024) & (US$ Million)
    Table 120. Cell and Gene Therapy Catapult Recent Development
    Table 121. MassBiologics Company Detail
    Table 122. MassBiologics Business Overview
    Table 123. MassBiologics Viral Vector and Plasmid DNA Product
    Table 124. MassBiologics Revenue in Viral Vector and Plasmid DNA Business (2019-2024) & (US$ Million)
    Table 125. MassBiologics Recent Development
    Table 126. Biovian Company Detail
    Table 127. Biovian Business Overview
    Table 128. Biovian Viral Vector and Plasmid DNA Product
    Table 129. Biovian Revenue in Viral Vector and Plasmid DNA Business (2019-2024) & (US$ Million)
    Table 130. Biovian Recent Development
    Table 131. VGXI Company Detail
    Table 132. VGXI Business Overview
    Table 133. VGXI Viral Vector and Plasmid DNA Product
    Table 134. VGXI Revenue in Viral Vector and Plasmid DNA Business (2019-2024) & (US$ Million)
    Table 135. VGXI Recent Development
    Table 136. Gene Synthesis Company Detail
    Table 137. Gene Synthesis Business Overview
    Table 138. Gene Synthesis Viral Vector and Plasmid DNA Product
    Table 139. Gene Synthesis Revenue in Viral Vector and Plasmid DNA Business (2019-2024) & (US$ Million)
    Table 140. Gene Synthesis Recent Development
    Table 141. PlasmidFactory Company Detail
    Table 142. PlasmidFactory Business Overview
    Table 143. PlasmidFactory Viral Vector and Plasmid DNA Product
    Table 144. PlasmidFactory Revenue in Viral Vector and Plasmid DNA Business (2019-2024) & (US$ Million)
    Table 145. PlasmidFactory Recent Development
    Table 146. Jikai Gene Company Detail
    Table 147. Jikai Gene Business Overview
    Table 148. Jikai Gene Viral Vector and Plasmid DNA Product
    Table 149. Jikai Gene Revenue in Viral Vector and Plasmid DNA Business (2019-2024) & (US$ Million)
    Table 150. Jikai Gene Recent Development
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Viral Vector and Plasmid DNA Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Viral Vector and Plasmid DNA Market Share by Type: 2023 VS 2030
    Figure 3. Plasmid DNA Features
    Figure 4. Viral Vector Features
    Figure 5. Global Viral Vector and Plasmid DNA Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Viral Vector and Plasmid DNA Market Share by Application: 2023 VS 2030
    Figure 7. Cancer Case Studies
    Figure 8. Virus Infection Case Studies
    Figure 9. Hereditary Disease Case Studies
    Figure 10. Viral Vector and Plasmid DNA Report Years Considered
    Figure 11. Global Viral Vector and Plasmid DNA Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Viral Vector and Plasmid DNA Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Viral Vector and Plasmid DNA Market Share by Region: 2023 VS 2030
    Figure 14. Global Viral Vector and Plasmid DNA Market Share by Players in 2023
    Figure 15. Global Top Viral Vector and Plasmid DNA Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector and Plasmid DNA as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Viral Vector and Plasmid DNA Revenue in 2023
    Figure 17. North America Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Viral Vector and Plasmid DNA Market Share by Country (2019-2030)
    Figure 19. United States Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Canada Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Viral Vector and Plasmid DNA Market Share by Country (2019-2030)
    Figure 23. Germany Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. France Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. U.K. Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Italy Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Russia Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Nordic Countries Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Viral Vector and Plasmid DNA Market Share by Region (2019-2030)
    Figure 31. China Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Japan Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. South Korea Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Southeast Asia Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. India Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Australia Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Viral Vector and Plasmid DNA Market Share by Country (2019-2030)
    Figure 39. Mexico Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Brazil Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Viral Vector and Plasmid DNA Market Share by Country (2019-2030)
    Figure 43. Turkey Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Saudi Arabia Viral Vector and Plasmid DNA Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Brammer Bio Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2019-2024)
    Figure 46. Oxford BioMedica Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2019-2024)
    Figure 47. Cobra Biologics Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2019-2024)
    Figure 48. FinVector Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2019-2024)
    Figure 49. Lonza Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2019-2024)
    Figure 50. BioReliance Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2019-2024)
    Figure 51. MolMed Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2019-2024)
    Figure 52. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2019-2024)
    Figure 53. UniQure Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2019-2024)
    Figure 54. Aldevron Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2019-2024)
    Figure 55. Richter-Helm Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2019-2024)
    Figure 56. Eurogentec Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2019-2024)
    Figure 57. OBiO Technology Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2019-2024)
    Figure 58. Yposkesi Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2019-2024)
    Figure 59. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2019-2024)
    Figure 60. MassBiologics Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2019-2024)
    Figure 61. Biovian Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2019-2024)
    Figure 62. VGXI Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2019-2024)
    Figure 63. Gene Synthesis Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2019-2024)
    Figure 64. PlasmidFactory Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2019-2024)
    Figure 65. Jikai Gene Revenue Growth Rate in Viral Vector and Plasmid DNA Business (2019-2024)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global RNA and DNA Extraction Kit Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-36Z8348
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global DNA Library Preparation Kits Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-5U6259
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Edible Insects Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20A9325
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global DNA Repair Proteins And Reagents Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-9S9524
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions